Related Experiment Videos
[Improvements in intra-arterial chemotherapy]
1HNO-Abteilung, Allgemeinen Krankenhauses Altona, Hamburg.
Laryngo- Rhino- Otologie
|March 18, 1999
Summary
The bypass method for intraarterial chemotherapy in head and neck cancer is a safe and effective technique. This study found it technically sound, with no device failures, and observed complete remission in half of the treated patients.
Area of Science:
- Oncology
- Chemotherapy
- Head and Neck Cancer
Context:
- Intraarterial (i.a.) chemotherapy for head and neck cancer is an evolving area of research.
- The bypass method represents a significant advancement in i.a. chemotherapy delivery.
- This study details experiences with the bypass method and recent international developments.
Purpose:
- To evaluate the efficacy and safety of the bypass method for intraarterial chemotherapy in head and neck cancer patients.
- To report on clinical experiences and outcomes using this specific i.a. chemotherapy delivery technique.
Summary:
- Twenty-eight patients with head and neck cancer received intraarterial Cisplatin via the bypass route between 1989 and 1998.
- Sixteen patients completed the planned chemotherapy, while some experienced mild side effects leading to early termination.
- Complete remission was observed in 12 out of 24 cases, and anticoagulation prevented technical complications.
Impact:
- The bypass method is a technically robust approach for intraarterial infusion when administered by experienced teams.
- This technique offers a viable treatment option for head and neck cancers, with potential for remission.